4 insights to kick-start your day, featuring PharmEasy’s funding winter

Uneasy times In the news. PharmEasy fails to get fresh funding, breaches covenant on Goldman Sachs loan, reports Economic Times Inside the news. A fast-growing startup, which was hotly pursued by venture capital-private equity investors during the bull run and raised about USD670 million in just a year (2021), is now struggling to close a USD150 million funding despite trying for a year. The down round, the capital crunch, an abandoned IPO plan